자료실 학회소개 학회소식 학술행사 분과전문의 자료실 학회지(JGO) 관련 사이트 최신 논문 가이드라인 Position Statement 보험 고시 사전신청요법 KSGO 회원 논문으로 보는 최신연구 최신 논문 부인암 수술동의서 부인암 수기
전체 전체 난소암 자궁경부암 자궁체부암 기타암 검색 제목 + 내용 작성자 검색 검색 초기화 총 게시글 : 136 Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology consensus statement 2024-03-29 VIEW : 12 Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant Chemotherapy 2023-12-26 VIEW : 41 Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer 2023-12-26 VIEW : 18 Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial 2023-12-26 VIEW : 54 Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer 2023-12-26 VIEW : 9 Reducing Unnecessary Oophorectomies for Benign Ovarian Neoplasms in Pediatric Patients 2023-12-26 VIEW : 4 Safety and antitumour activity of cadonilimab, an anti- PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial 2023-12-26 VIEW : 3 Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial 2023-12-26 VIEW : 12 Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer SubgroupAnalysesfromtheKEYNOTE-826RandomizedClinicalTrial 2023-12-26 VIEW : 9 Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update 2023-09-19 VIEW : 52 Tyrosine kinase inhibitor toxicities: A society of gynecologic oncology review and recommendations 2023-09-19 VIEW : 16 Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994 / JCO 2023-09-19 VIEW : 34 Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study 2023-09-19 VIEW : 14 Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients – An international pooled analysis of three ESGO accredited centres 2023-09-19 VIEW : 43 Intrauterine manipulator during hysterectomy for endometrial cancer: a systematic review and meta-analysis of oncologic outcomes. 2023-09-19 VIEW : 21 1 2 3 4 5 6 7 8 9 10